With box warnings

Without box warnings

Branded

Generic

4 results

bimzelx
(bimekizumab)
UCB, Inc.
Usage: BIMZELX is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, active non-radiographic axial spondyloarthritis with inflammation, active ankylosing spondylitis, and moderate to severe hidradenitis suppurativa in adults who qualify for systemic therapy or phototherapy.
cosentyx
(secukinumab)
Novartis Pharmaceuticals Corporation
Usage: COSENTYX is indicated for treating moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis from age 2, adult ankylosing spondylitis, active non-radiographic axial spondyloarthritis, active enthesitis-related arthritis in patients 4 years and older, and moderate to severe hidradenitis suppurativa in adults.
rinvoq
(Upadacitinib)
AbbVie Inc.
Usage: RINVOQ is indicated for adults and pediatric patients (2+) with various conditions, including moderately to severely active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, after inadequate response to TNF blockers.
taltz
(ixekizumab)
Eli Lilly and Company
Usage: TALTZ is indicated for the treatment of moderate-to-severe plaque psoriasis in patients aged 6 and older, as well as for adults with active psoriatic arthritis, ankylosing spondylitis, and active non-radiographic axial spondyloarthritis with objective signs of inflammation.

Medications for Nonradiographic Axial Spondyloarthritis

bimzelx